pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
trilaciclib
Cosela (trilaciclib)
Triple-Negative Breast Cancer (TNBC)
Pharmacosmos AS
Preclinical
trimeprazine tartrate
Temaril (trimeprazine tartrate)
Trigeminal Neuralgia (Tic Douloureux)
Undaunted Bio Inc
Phase 2
trimetazidine
trimetazidine [INN]
Contrast Induced Nephropathy
Saghmos Therapeutics Inc
Marketed
← prev
page 265 of 271
next →
Pain
89
Neurology
1
trimethobenzamide
Trimethobenzamide Hydrochloride (trimethobenzamide [INN])
Nausea
Gavis Pharmaceuticals LLC
Marketed
trimethoprim
Trimethoprim
Urinary Tract Infections
Novel Laboratories Inc
Phase 2
troculeucel
troculeucel [INN]
Alzheimer's Disease
NKGen Biotech Inc
Marketed
tromethamine
Tromethamine
Metabolic Acidosis
Milla Pharmaceuticals Inc
Phase 3
trontinemab
trontinemab
Alzheimer's Disease
F. Hoffmann-La Roche Ltd
Marketed
tropicamide
Mydriacyl (tropicamide)
Cycloplegia
Alcon Laboratories Inc
Marketed
trospium chloride
Trospium Chloride
Overactive Bladder
InvaGen Pharmaceuticals Inc
Marketed
trospium chloride ER
Trospium Chloride
Overactive Bladder
Granules Pharma LLC
Phase 2
trovostobart
trovostobart [INN]
Bladder Cancer
TuHURA Biosciences Inc
Marketed
tucatinib
Tukysa (tucatinib)
Metastatic Colorectal Cancer
Seagen Inc
Phase 2
tucidinostat
tucidinostat
Metastatic Melanoma
HUYA Bioscience International LLC
Phase 2
tulmimetostat
tulmimetostat
Endometrial Cancer
$NVS
NOVARTIS AG
Phase 2
tuspetinib
tuspetinib
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$APTOF
Aptose Biosciences Inc.
Phase 2
tuvatexib
tuvatexib [INN]
Actinic (Solar) Keratosis
Vidac Pharma
Marketed
typhoid Vi polysaccharide [strain S typhi Ty2] vaccine
Typhim Vi
Typhoid Fever
Sanofi Pasteur Inc
Marketed
typhoid [strain salmonella typhi Ty21a] vaccine DR
Vivotif
Typhoid Fever
Bavarian Nordic AS
Marketed
ubrogepant
Ubrelvy (ubrogepant)
Migraine
$ABBV
AbbVie Inc.
Phase 3
udenafil
udenafil
Congenital Heart Disease
Mezzion Pharma Co Ltd
Phase 2
ulacamten
ulacamten
Diastolic Heart Failure (HFpEF)
$CYTK
CYTOKINETICS INC
Phase 3
ulefnersen sodium
ulefnersen sodium
Amyotrophic Lateral Sclerosis
Otsuka Pharmaceutical Co Ltd
Phase 2
ulenistamab
ulenistamab [INN]
Metastatic Pancreatic Cancer
Prestige BioPharma Ltd
Marketed
ulipristal acetate
Logilia (ulipristal acetate)
Female Contraception
Teva Pharmaceuticals USA Inc
pre_registration
ulixacaltamide hydrochloride
ulixacaltamide hydrochloride
Essential Tremor
$PRAX
Praxis Precision Medicines, Inc.
Preclinical
ulodesine
ulodesine
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Helix BioPharma Corp
Phase 3
ulotaront hydrochloride
ulotaront hydrochloride
Generalized Anxiety Disorder (GAD)
Otsuka Pharmaceutical Co Ltd
Phase 3
ulviprubart
ulviprubart
Inclusion Body Myositis (IBM)
Abcuro Inc
Marketed
umeclidinium bromide
Incruse Ellipta (umeclidinium bromide)
Chronic Bronchitis
GlaxoSmithKline LLC
